Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders

E-ISSN： 1875-6662|13|2|107-128

ISSN： 1573-4080

Source： Current Enzyme Inhibition, Vol.13, Iss.2, 2017-06, pp. : 107-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Isolation and characterization of a novel glycogen synthase kinase-3 gene, GmGSK , in Glycine max L. that enhances abiotic stress tolerance in Saccharomyces cerevisiae

By Zhang Chunbao

Biotechnology Letters, Vol. 32, Iss. 6, 2010-06 ,pp. : 861-866

Springer Publishing Company

Access to resources Recommend Favorite

Proteomics: drug target discovery on an industrial scale

By Ryan T.E. Patterson S.D.

Trends in Biotechnology, Vol. 20, Iss. 12, 2002-12 ,pp. : 45-51

Elsevier

Access to resources Recommend Favorite

Full-speed mammalian genetics: in vivo target validation in the drug discovery process

By Abuin A. Holt K.H. Platt K.A. Sands A.T. Zambrowicz B.P.

Trends in Biotechnology, Vol. 20, Iss. 1, 2002-01 ,pp. : 36-42

Elsevier

Access to resources Recommend Favorite

Dual-purpose drug discovery

By Wagner B.K. Clemons P.A.

Trends in Biotechnology, Vol. 20, Iss. 12, 2002-12 ,pp. : 492-493

Elsevier

Access to resources Recommend Favorite

Designing combinatorial libraries for drug discovery

By Lobanov V.S.

Trends in Biotechnology, Vol. 20, Iss. 2, 2002-02 ,pp. : 86-87

Elsevier

Access to resources Recommend Favorite